Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the physiological actions of GLP-1, a hormone secreted by https://socialfactories.com/story6312082/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes